While we’re still far away from finding an actual cure for cancer, it’s undeniable that the world has made progress in ...

Federal health officials have issued a warning about controversial statements made by biotech billionaire Dr. Patrick ...

Dr. Richard Rovin, a neurosurgeon at Aurora St. Lukes Medical Center in Milwaukee came home from work in 2002 and his wife, a ...

March 24 () - The European Union's medicines regulator said on Tuesday it expects Baxter International's ‌cancer drugs ...

Pegvisomant, developed by professor John Kopchick in 1987, shows potential to make treatment-resistant lung cancer cells more ...

SNV4818 is an oral treatment currently being evaluated in an early and mid-stage study for breast cancer and other advanced ...

Immunotherapy has been one of the most transformative treatments for cancer patients in recent decades, shifting the emphasis ...

A new immunotherapy drug used in a prostate cancer clinical trial is showing early promise in possible treatment of the disease.

A new study sheds light on why promising cancer treatments can produce dramatically different results across patients.

Scientists have engineered probiotic bacteria to act as tumor-seeking drug factories. In mice, these bacteria infiltrated ...

GSK plc GSK announced that Japan’s Ministry of Health, Labour and Welfare has granted Orphan Drug Designation (ODD) to ...

Dizal Pharmaceutical's Zegfrovy has taken the EGFR inhibitor class into new territory after hitting the mark in a phase 3 ...